Related Experiment Video
Updated: Nov 27, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
TCR Gene Therapy: Challenges, Opportunities, and Future Directions
Hans J Stauss1, Maxine G B Tran2
1Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, UK.
Adoptive immunotherapy using gene-engineered T cells offers novel cancer treatment strategies. This approach enhances the patient's immune system to target and eliminate cancer cells effectively.
Area of Science:
- Oncology
- Immunology
- Gene Therapy
Background:
- Adoptive immunotherapy harnesses the patient's immune system for cancer treatment.
- Gene-engineered T cells represent a promising advancement in this field.
- This therapy aims to provide new options for cancer patients.
Discussion:
- Discusses the mechanisms of gene-engineered T cell therapy.
- Explores the potential and challenges of this innovative cancer treatment.
- Highlights the significance of T cell engineering in immunotherapy.
Key Insights:
- Gene-engineered T cells offer targeted cancer cell elimination.
- This immunotherapy approach provides new therapeutic avenues.
- Significant progress has been made in developing T cell-based cancer treatments.
Outlook:
- Future research directions in adoptive immunotherapy.
- Potential for broader application of gene-engineered T cells in oncology.
- Advancements in enhancing T cell efficacy and persistence for long-term cancer control.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
11:21Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs
Published on: September 10, 2017
Related Concept Videos
Gene Therapy
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...